Silo Pharma, Inc.
SILO
Last
$1.47
Day
+1.4%
1y
-85.3%
5y
-99.0%
52w
-86.1%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1232d
EMA 21
1.74
EMA 50
2.52
EMA 200
5.08
20d high
-34.1%
5y high
-99.2%
5y range
0th
Positions held
Your positionsSILO isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-6
Hold
avoid
Signal
Sell
Target
$1.65
Stop
$1.29
Stop distance
12.2%
Target vs last
+12.2%
Fundamentals
| Market cap | $2.98M | Enterprise value | -$2.92M | Trailing P/E | — | Forward P/E | -2.07 |
| PEG | — | Price / book | 0.33 | Beta | 0.91 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | -14.8% | Operating margin | -82.5% |
| Profit margin | 0.0% | ROE | -91.2% | ROA | -44.2% | Debt / equity | — |
| Current ratio | 5.36 | Free cash flow | -$1.64M | Analyst recommendation | none | Mean target | — |
| 52w high | $10.44 | 52w low | $1.30 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | -8846.4% | -4363.3% | -6388.2% | -6926.8% | — |
| Net income | -$0.8M | -$1.6M | -$0.9M | -$1.1M | -$1.2M | — |
| Gross margin | — | -14.8% | -14.8% | -14.8% | 91.9% | — |
| Gross profit | $0.0M | -$0.0M | -$0.0M | -$0.0M | $0.0M | — |
| Operating income | -$0.9M | -$1.6M | -$0.8M | -$1.2M | -$1.2M | — |
- Revenue -100% vs prior quarter ($0 vs $0.0M).
- Gross margin -14.8% (was -14.8% prior quarter).
- Operating margin compressed to -8846.4%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.1M | $0.1M | $0.1M | $0.1M | — |
| Op margin | -5937.0% | -6526.4% | -5347.4% | -5059.0% | — |
| Net income | -$4.2M | -$4.4M | -$3.7M | -$3.9M | — |
| Gross margin | 38.6% | 91.9% | 91.9% | 91.9% | — |
| Gross profit | $0.0M | $0.1M | $0.1M | $0.1M | — |
| Operating income | -$4.3M | -$4.7M | -$3.9M | -$3.6M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-08-18 · Silo Pharma Gets Canadian Patent Allowance for Stress Disorder Treatment
2026-07-15 · Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform?
2026-07-14 · Silo Pharma’s QwikAgents Joins AMD AI Developer Program to Advance AI Agent Platform
2026-07-14 · Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform
Price (daily)
Full chart · RSI · MACD · patternsSILO · daily-15.7% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin